Physician

Adam Donald Stallmer, MD

According to 2025 Medicare claims, Adam Stallmer, MD (NPI: 1356501480) practices hospitalist in the Albany-Schenectady-Troy, NY market, with the plurality of this provider's patient population coming from Rensselaer, NY. This provider's primary affiliated billing organization is CAPITAL CARDIOLOGY ASSOCIATES PLLC (NPI: 1518952332; TIN: 141834454) and primary practice location at 12180-2466. Stallmer is affiliated with the Trinity Health Integrated Care (ACO ID: A3454), participating under the MSSP model.

Stallmer's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 434 traditional Medicare patients, billed 1,034 HCPCS/CPT codes, and received $89,556 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 370 prescription claims across 83 beneficiaries totaling $27,143 in drug costs, led by Brilinta (Ticagrelor). 2020 DME data shows 36 claims. Open Payments data shows 20 records totaling $440. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $31,021 and ending at $27,143. For DME billing, reported payments rose steadily, from $4,571 to $22,778.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	474	1,107	$80,925
2016	413	881	$66,344
2017	316	792	$57,730
2018	291	550	$42,969
2019	258	339	$28,606
2020	13	20	$1,574
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	429	912	$80,062
2024	434	1,034	$89,556

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	167	530	$31,021
2016	180	594	$31,291
2017	159	431	$20,255
2018	160	423	$19,631
2019	83	241	$19,199
2020	98	338	$17,162
2021	99	357	$20,436
2022	66	263	$23,026
2023	105	624	$68,157
2024	83	370	$27,143

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	13	119	$3,793
2016	N/R	16	$113
2017	N/R	30	$1,516
2018	N/R	69	$3,338
2019	N/R	67	$2,702
2020	N/R	36	$2,010
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	235	276	$129
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	166	305	$89
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	251	384	$59
99283	Emergency department visit with low level of medical decision making	11	11	$53
99231	Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes	33	38	$37

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Brilinta	Ticagrelor	41	1,220	$17,703
Atorvastatin Calcium	Atorvastatin Calcium	69	2,130	$431
Nitroglycerin	Nitroglycerin	13	315	$232
Metoprolol Succinate	Metoprolol Succinate	36	1,140	$136
Clopidogrel	Clopidogrel Bisulfate	20	715	$73

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	20	$440	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Adam Donald Stallmer, MD?

Tedicare shows public-source Medicare data for Adam Donald Stallmer, MD (NPI 1356501480), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adam Donald Stallmer, MD have ACO affiliation data?

Adam Donald Stallmer, MD is shown with ACO affiliation data for Trinity Health Integrated Care (MSSP, ACO ID A3454).

What billing organization is linked to Adam Donald Stallmer, MD?

Adam Donald Stallmer, MD is linked to CAPITAL CARDIOLOGY ASSOCIATES PLLC (billing NPI 1518952332) in the available physician profile data.

Does Adam Donald Stallmer, MD have Open Payments data?

Adam Donald Stallmer, MD has 20 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.